Worldwide Drug Modeling Software Industry to 2027 – Increasing Adoption of Modelling Tools in Drug Discovery is Driving Growth
DUBLIN, Oct. 2, 2020 /PRNewswire/ — The “Drug Modeling Software Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Product type; Application, and Geography” report has been added to ResearchAndMarkets.com’s offering.
According to this report the global drug modeling software biopharmaceutical market is expected to reach US$ 11,299.85 million by 2027 from US$ 6,205.22 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report highlights the trends prevalent in the global drug modeling software market, and the drivers and deterrents pertaining to its growth.
Based on product type, the drug modeling software market is segmented into database, software, and others. In terms of product type, the software segment held the highest share of the drug modeling software market in 2019 and is estimated to register the highest CAGR of 8.4% in the market during the forecast period. The growth of the market is attributed to the growing demand for effective therapeutics and increasing number of drug discovery efforts of various biologics across a wide range of therapeutics. Additionally, strategic activities by service providers such as collaborations, product advancement, and product launch in order to expedite drug discovery timeline are further accelerating the growth of the market.
The market growth is also attributed to a few key factors such as increasing adoption of in-silico modeling tools in drug discovery, and rising economic burden of drug discovery. However, less adoption in emerging countries is expected to hamper the growth of the market up to certain extent during the forecast period.
Crown Bioscience Inc.; Chemical Computing Group Ulc; Nimbus Therapeutics; Schrdinger, Inc.; Dassault Systmes; Genedata Ag; Biognos Ab; Compugen Ltd; Acellera ltd.; and Leadscope, Inc plc are among the prominent players operating in the drug modeling software market. The market players
Outlook online users around the world are reporting problems accessing the Microsoft service, adding to the woes Office 365 users experienced earlier this week.
Microsoft at 9am CET, 3am ET, confirmed that users are having issues accessing Exchange Online accounts via Outlook on the web.
SEE: Office 365: A guide for tech and business leaders (free PDF) (TechRepublic download)
Microsoft initially said users in India are the primary group impacted. However, the company later confirmed on the Microsoft 365 Status Twitter account that the issue is affecting users worldwide.
Downloaddetector currently indicates the worst impacted regions include the UK, France, Germany, Netherlands, Belgium, Norway, Sweden, and India. There are also multiple user reports on Twitter from users in Europe who’ve been unable to access Outlook as the workday begins.
This new incident follows a six-hour Office 365 failure earlier this week due to an authentication error that prevented users from signing into Office.com, Outlook.com, Teams, Power Platform, and Dynamics365. Microsoft was forced to roll back a recent change that impacted authentication operations for numerous Microsoft and Azure services.
Microsoft’s Office Service health dashboard also confirms that users of Outlook.com “may be unable to access their email”.
“We’re collecting additional data from the affected infrastructure to aid in our investigation to determine the cause of impact,” Microsoft said.
SEE: Office 365 outage with roll back failure ends after more than six hours
Similar to the incident earlier this week, Microsoft said it is investigating recent updates it has made to its service to